In vitro, single-agent treatment with novobiocin or ART558 caused a significant cytotoxic effect at physiologically relevant concentrations in ATM-deficient cells…Our data has the potential to uncover novel biomarker-driven drug therapy of POLQ inhibitors in R/R MCL.